These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15306839)

  • 1. Safety and biodistribution studies of an HSV multigene vector following intracranial delivery to non-human primates.
    Wolfe D; Niranjan A; Trichel A; Wiley C; Ozuer A; Kanal E; Kondziolka D; Krisky D; Goss J; Deluca N; Murphey-Corb M; Glorioso JC
    Gene Ther; 2004 Dec; 11(23):1675-84. PubMed ID: 15306839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery.
    Niranjan A; Wolfe D; Tamura M; Soares MK; Krisky DM; Lunsford LD; Li S; Fellows-Mayle W; DeLuca NA; Cohen JB; Glorioso JC
    Mol Ther; 2003 Oct; 8(4):530-42. PubMed ID: 14529825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses.
    Sandmair AM; Loimas S; Puranen P; Immonen A; Kossila M; Puranen M; Hurskainen H; Tyynelä K; Turunen M; Vanninen R; Lehtolainen P; Paljärvi L; Johansson R; Vapalahti M; Ylä-Herttuala S
    Hum Gene Ther; 2000 Nov; 11(16):2197-205. PubMed ID: 11084677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
    Kramm CM; Rainov NG; Sena-Esteves M; Barnett FH; Chase M; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Oct; 7(16):1989-94. PubMed ID: 8930659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
    Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
    Kramm CM; Chase M; Herrlinger U; Jacobs A; Pechan PA; Rainov NG; Sena-Esteves M; Aghi M; Barnett FH; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1997 Nov; 8(17):2057-68. PubMed ID: 9414254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
    Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
    Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z; Culver KW; Walbridge S; Frank JA; Blaese RM; Oldfield EH
    J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
    Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
    Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
    Packer RJ; Raffel C; Villablanca JG; Tonn JC; Burdach SE; Burger K; LaFond D; McComb JG; Cogen PH; Vezina G; Kapcala LP
    J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.
    Smith JG; Raper SE; Wheeldon EB; Hackney D; Judy K; Wilson JM; Eck SL
    Hum Gene Ther; 1997 May; 8(8):943-54. PubMed ID: 9195217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
    Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.